Bioven Sdn. Bhd.
🇲🇾Malaysia
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV
Phase 2
Terminated
- Conditions
- Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV
- First Posted Date
- 2007-08-15
- Last Posted Date
- 2011-09-30
- Lead Sponsor
- Bioven Sdn. Bhd.
- Target Recruit Count
- 230
- Registration Number
- NCT00516685
- Locations
- 🇲🇾
Local Institution, Kuala Lumpur, Malaysia
News
No news found